Zeltiq Aesthetics Inc  

(Public, NASDAQ:ZLTQ)   Watch this stock  
Find more results for Zeltiq Aesthetics Inc´┐Ż
20.98
+0.64 (3.15%)
After Hours: 20.98 0.00 (0.00%)
Feb 10, 4:44PM EST  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 20.39 - 21.44
52 week 19.34 - 38.49
Open 20.39
Vol / Avg. 0.00/1.15M
Mkt cap 829.78M
P/E 368.20
Div/yield     -
EPS 0.06
Shares 39.03M
Beta 0.59
Inst. own 111%
Mar 1, 2016
Q4 2015 ZELTIQ Aesthetics Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Feb 10, 2016
ZELTIQ Aesthetics Inc at Leerink Partners Global Healthcare Conference
Jan 13, 2016
ZELTIQ Aesthetics Inc at JPMorgan Healthcare Conference - Webcast
Dec 1, 2015
ZELTIQ Aesthetics Inc at Piper Jaffray Healthcare Conference - Webcast
Nov 19, 2015
ZELTIQ Aesthetics Inc at Canaccord Genuity Medical Technology & Diagnostics Forum - Webcast
Nov 19, 2015
ZELTIQ Aesthetics Inc at Goldman Sachs US Emerging & SMID Cap Growth Conference - Webcast
Nov 18, 2015
ZELTIQ Aesthetics Inc at Stifel Healthcare Conference
Nov 17, 2015
ZELTIQ Aesthetics Inc Investor and Analyst Day
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin 3.51% 0.88%
Operating margin 3.16% 1.22%
EBITD margin - 2.26%
Return on average assets 6.88% 1.60%
Return on average equity 11.23% 2.30%
Employees 408 -
CDP Score - -

Address

4698 Willow Rd Ste 100
PLEASANTON, CA 94588-2806
United States - Map
+1-925-4742500 (Phone)
+1-925-4742599 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

ZELTIQ Aesthetics, Inc. is a medical technology company. The Company is focused on developing and commercializing products utilizing its controlled-cooling technology platform. Its commercial product, the CoolSculpting System, is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system to dermatologists, plastic surgeons and aesthetic specialists and generates revenue from sales of its CoolSculpting system and from sales of consumables to its customers. Consumables are the CoolSculpting procedure packs that it sells, which are needed to perform procedures using its CoolSculpting system. As of December 31, 2014, it had an installed base of 3,176 CoolSculpting systems installed across approximately 2,688 practices across the world. As of December 31, 2014, 1.5 million CoolSculpting cycles had been shipped to its customers and distributors.

Officers and directors

Mark J. Foley President, Chief Executive Officer, Director
Age: 50
Bio & Compensation  - Reuters
Patrick F Williams Chief Financial Officer, Senior Vice President
Age: 42
Bio & Compensation  - Reuters
Keith Sullivan Chief Commercial Officer and President, North America
Age: 57
Bio & Compensation  - Reuters
Sergio Garcia-Rodriguez Senior Vice President, General Counsel and Corporate Secretary
Age: 53
Bio & Compensation  - Reuters
Leonard C. DeBenedictis Chief Technology Officer
Age: 73
Bio & Compensation  - Reuters
Carl H. Lamm Vice President of Operations
Age: 52
Bio & Compensation  - Reuters
Mary M. Fisher Independent Director
Age: 53
Bio & Compensation  - Reuters
D. Keith Grossman Independent Director
Bio & Compensation  - Reuters
Kevin C. O'Boyle CPA Independent Director
Age: 59
Bio & Compensation  - Reuters
Bryan E. Roberts Ph.D. Independent Director
Age: 48
Bio & Compensation  - Reuters